|
Borchardt, P E; Quadri, S M; Freedman, R S et al. (2000) Intraperitoneal radioimmunotherapy with human monoclonal IGM in nude mice with peritoneal carcinomatosis. Cancer Biother Radiopharm 15:53-64
|
|
Quadri, S M; Vriesendorp, H M (1998) Effects of linker chemistry on the pharmacokinetics of radioimmunoconjugates. Q J Nucl Med 42:250-61
|
|
Borchardt, P E; Quadri, S M; Freedman, R S et al. (1998) Indium-111- and yttrium-90-labeled human monoclonal immunoglobulin M targeting of human ovarian cancer in mice. J Nucl Med 39:476-84
|
|
Vriesendorp, F J; Quadri, S M; Flynn, R E et al. (1997) Preclinical analysis of radiolabeled anti-GD2 immunoglobulin G. Cancer 80:2642-9
|
|
Borchardt, P E; Quadri, S M; Freedman, R S et al. (1997) Intralesional radiolabeled human monoclonal IgM in human tumor xenografts. Radiother Oncol 44:283-93
|
|
Vriesendorp, H M; Quadri, S M; Jaeckle, K A et al. (1996) Proposal for translational analysis and development of clinical radiolabeled immunoglobulin therapy. Radiother Oncol 41:151-61
|
|
Quadri, S M; Malik, A B; Chu, H B et al. (1996) Intraperitoneal indium-111- and yttrium-90-labeled human IgM (AC6C3-2B12) in nude mice bearing peritoneal carcinomatosis. J Nucl Med 37:1545-51
|
|
Ali, M S; Quadri, S M (1996) Maleimido derivatives of diethylenetriaminepentaacetic acid and triethylenetetraaminehexaacetic acid: their synthesis and potential for specific conjugation with biomolecules. Bioconjug Chem 7:576-83
|
|
Vriesendorp, H M; Morton, J D; Quadri, S M (1995) Review of five consecutive studies of radiolabeled immunoglobulin therapy in Hodgkin's disease. Cancer Res 55:5888s-5892s
|
|
Quadri, S M; Siddiqui, A; Klein, J L et al. (1995) Biodistribution and tumor localization of 111In-labeled unmodified and modified F(ab')2 fragments of human monoclonal IgM (16.88) in a nude mouse model. Nucl Med Biol 22:413-23
|
Showing the most recent 10 out of 15 publications
